ALSF Childhood Cancer Research Grants
With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Targeting the Surface-ome of Embryonal Brain Tumors||Institut Curie / Olivier Ayrault, PhD||Crazy 8 Pilots||2019|
|Novel Therapy of Heterogeneous B-cell Acute Lymphocytic Leukemia by Targeting Convergent Oncogenic Mediators STATs||University of Alberta / Hasan Uludag, PhD||Innovation Grants||2019||Alberta|
|Multiplex Ion Beam Imaging of Pediatric Cancers||Stanford University School of Medicine / Crystal L. Mackall, MD||Crazy 8 Pilots||2019||California|
|A comprehensive public resource for fusion-negative sarcoma sequencing data||University of California San Francisco / Alejandro Sweet-Cordero, MD & Richard Gorlick, MD||Crazy 8 Pilots||2019||California|
|Saturating CRISPR gene body scans in MLL-rearranged leukemia||Beckman Research Institute of City of Hope / Chun-Wei Chen, PhD||Innovation Grants||2019||California|
|The Role of Tumor Heterogeneity in Relapse of Pediatric Acute Myeloid Leukemia||Children's Hospital & Research Center at Oakland / Cheryl Peretz, MD||Young Investigator Grants||2019||California|
|MLL Oncogene-Dependent Enhancer Reprogramming Promotes Leukemogenesis||Stanford University / Feng Pan, PhD||Young Investigator Grants||2019||California|
|Synergistic Activity of Anti-GD2 Antibody and CD47-Blockade for Immunotherapy of Neuroblastoma and Osteosarcoma||The Board of Trustees of the Leland Stanford Junior University / Robbie Majzner, MD||'A' Award Grants||2019||California|
|Optimizing TCRαβ+/CD19+-depleted haploidentical HSCT for ALL using donor-derived genome-edited CAR T cells||Stanford University School of Medicine / Alice Bertaina, MD/PhD||Reach Grants||2019||California|
|Preclinical Development of a First-in-Class PCNA Inhibitor for Treating Neuroblastoma||City of Hope National Medical Center / Linda Malkas, PhD||Reach Grants||2019||California|